Product Information
OTEZLA 30 MG TABLET is a brand product labeled by Amgen Inc., priced at $90.4849 per EA under NDC 55513013760. Its NADAC has been published 307 times since Aug 12, 2020.
Strength
30 mg/1
Manufacturer
Amgen Inc.NDC
55513013760
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
APREMILASTApproval Type
New Drug (NDA)
FDA Application
NDA205437On Market Since
2/26/2020
Pharmacological Classes
Price Statistics
The NADAC for OTEZLA 30 MG TABLET has been published 307 times since Aug 12, 2020, and over the history we have for it it has risen 55.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $90.4849 per EA |
|---|---|
| All-time high | $90.6993 (May 13, 2026) |
| All-time low | $58.0877 (Oct 21, 2020) |
| 52-week high | $90.6993 |
| 52-week low | $86.3631 |
| Median price | $74.4027 |
| Average price | $74.5073 |
| Largest weekly change | +7.4% (Feb 2, 2022) |
| Weeks tracked | 307 |
| Tracking since | Aug 12, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the apremilast market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OTEZLA 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OTEZLA 30 MG TABLET, manufactured by Amgen Inc., is $90.4849 per EA (NDC 55513013760), effective Jun 24, 2026.
How has the price of OTEZLA 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for OTEZLA 30 MG TABLET has risen 55.5%. It has been tracked across 307 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for OTEZLA 30 MG TABLET?
Since Aug 12, 2020, the NADAC for OTEZLA 30 MG TABLET has ranged from a low of $58.0877 (Oct 21, 2020) to a high of $90.6993 (May 13, 2026), with a median of $74.4027 per EA.
Are there cheaper alternatives to OTEZLA 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OTEZLA 30 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures OTEZLA 30 MG TABLET?
OTEZLA 30 MG TABLET (NDC 55513013760) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification